In vitro fertilization and risk of breast and gynecologic cancers: A retrospective cohort study within the Israeli Maccabi Healthcare Services

Fertility and Sterility

Volumn 99, Issue 5, 2013, Pages 1189-1196

  Brinton, Louise A ^a   Trabert, Britton ^a   Shalev, Varda ^b,c   Lunenfeld, Eitan ^d   Sella, Tal ^b,d   Chodick, Gabriel ^b,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MACCABI HEALTHCARE SERVICES   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

cancer; In vitro fertilization (IVF); risk

Indexed keywords

CLOMIFENE; GESTAGEN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; FERTILIZATION IN VITRO; GYNECOLOGIC CANCER; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SMOKING; SOCIAL STATUS; UTERINE CERVIX CANCER; BREAST TUMOR; ENDOMETRIUM TUMOR; FEMALE GENITAL TRACT TUMOR; FOLLOW UP; HEALTH MAINTENANCE ORGANIZATION; MIDDLE AGED; OVARY TUMOR; PREGNANCY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICS; TIME; UTERINE CERVIX TUMOR;

ADULT; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; FERTILIZATION IN VITRO; FOLLOW-UP STUDIES; GENITAL NEOPLASMS, FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; ISRAEL; MIDDLE AGED; OVARIAN NEOPLASMS; PREGNANCY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84875736378     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.12.029     Document Type: Article

References (53)

1. M.A. Rossing, J.R. Daling, N.S. Weiss, D.E. Moore, and S.G. Self Ovarian tumors in a cohort of infertile women N Engl J Med 331 1994 771 776
2. A.S. Whittemore, R. Harris, J. Itnyre Collaborative Ovarian Cancer Group Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women Am J Epidemiol 136 1992 1184 1203
3. L.A. Brinton, V.V. Sahasrabuddhe, and B. Scoccia Fertility drugs and the risk of breast and gynecologic cancers Semin Reprod Med 30 2012 131 145
4. L.A. Brinton, E.J. Lamb, K.S. Moghissi, B. Scoccia, M.D. Althuis, and J.E. Mabie Ovarian cancer risk after the use of ovulation-stimulating drugs Obstet Gynecol 103 2004 1194 1203
5. M.L. Kurta, K.B. Moysich, J.L. Weissfeld, A.O. Youk, C.H. Bunker, and R.P. Edwards Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study Cancer Epidemiol Biomarkers Prev 21 2012 1282 1292
6. B.J. Mosgaard, O. Lidegaard, S.K. Kjaer, G. Schou, and A.N. Andersen Infertility, fertility drugs, and invasive ovarian cancer: a case-control study Fertil Steril 67 1997 1005 1012
7. R.B. Ness, D.W. Cramer, M.T. Goodman, S.K. Kjaer, K. Mallin, and B.J. Mosgaard Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies Am J Epidemiol 155 2002 217 224
8. Israel Center for Disease Control Health Status in Israel 1999 1999 Ministry of Health Tel Hahomer, Israel
9. Central Bureau of Statistics Census of Population and Housing 1998 Central Bureau of Statistics Jerusalem
10. D. Cox Regression models and life tables (with discussion) J R Stat Soc B 32 1972 187 220
11. T. Sella, G. Chodick, E. Lunenfeld, and V. Shalev Further evidence on the high prevalence of male factor infertility diagnosis in Israel Isr Med Assoc J 13 2011 386
12. R. Calderon-Margalit, Y. Friedlander, R. Yanetz, K. Kleinhaus, M.C. Perrin, and O. Manor Cancer risk after exposure to treatments for ovulation induction Am J Epidemiol 169 2009 365 375
13. A. Jensen, H. Sharif, K. Frederiksen, and S.K. Kjaer Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study BMJ 338 2009 b249
14. L.M. Stewart, C.D. Holman, P. Aboagye-Sarfo, J.C. Finn, D.B. Preen, and R. Hart In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk Gynecol Oncol 2 2013 4
15. K.L. Terry, W.C. Willett, J.W. Rich-Edwards, and K.B. Michels A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer Arch Intern Med 166 2006 2484 2489
16. L. Lerner-Geva, L. Keinan-Boker, T. Blumstein, V. Boyko, L. Olmar, and S. Mashiach Infertility, ovulation induction treatments and the incidence of breast cancer - a historical prospective cohort of Israeli women Breast Cancer Res Treat 100 2006 201 212
17. L.A. Brinton, B. Scoccia, K.S. Moghissi, C.L. Westhoff, M.D. Althuis, and J.E. Mabie Breast cancer risk associated with ovulation-stimulating drugs Hum Reprod 19 2004 2005 2013
18. L.G. Liat, R. Jaron, O. Liraz, B. Tzvia, M. Shlomo, and L. Bruno Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up Gynecol Endocrinol 10 2012 809 814
19. I. dos Santos Silva, P.A. Wark, V.A. McCormack, D. Mayer, C. Overton, and V. Little Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort Br J Cancer 100 2009 1824 1831
20. E. Gauthier, X. Paoletti, and F. Clavel-Chapelon Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study Hum Reprod 19 2004 2216 2221
21. A. Jensen, H. Sharif, E.I. Svare, K. Frederiksen, and S.K. Kjaer Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study Cancer Epidemiol Biomarkers Prev 16 2007 1400 1407
22. B. Kallen, O. Finnstrom, A. Lindam, E. Nilsson, K.G. Nygren, and O.P. Otterblad Malignancies among women who gave birth after in vitro fertilization Hum Reprod 26 2011 253 258
23. M.D. Althuis, K.S. Moghissi, C.L. Westhoff, B. Scoccia, E.J. Lamb, and J.H. Lubin Uterine cancer after use of clomiphene citrate to induce ovulation Am J Epidemiol 161 2005 607 615
24. A. Jensen, H. Sharif, and S.K. Kjaer Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study Am J Epidemiol 170 2009 1408 1414
25. A. Venn, L. Watson, F. Bruinsma, G. Giles, and D. Healy Risk of cancer after use of fertility drugs with in-vitro fertilisation Lancet 354 1999 1586 1590
26. A.N. Yli-Kuha, M. Gissler, R. Klemetti, R. Luoto, and E. Hemminki Cancer morbidity in a cohort of 9175 Finnish women treated for infertility Hum Reprod 27 2012 1149 1155
27. F.E. van Leeuwen, H. Klip, T.M. Mooij, A.M. van de Swaluw, C.B. Lambalk, and M. Kortman Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort Hum Reprod 26 2011 3456 3465
28. R. Harris, A.S. Whittemore, J. Itnyre Collaborative Ovarian Cancer Group Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women Am J Epidemiol 136 1992 1204 1211
29. F. Parazzini, E. Negri, C. La Vecchia, S. Moroni, A. Polatti, and F. Chiaffarino Treatment for fertility and risk of ovarian tumors of borderline malignancy Gynecol Oncol 68 1998 226 228
30. A. Shushan, O. Paltiel, J. Iscovich, U. Elchalal, T. Peretz, and J.G. Schenker Human menopausal gonadotropin and the risk of epithelial ovarian cancer Fertil Steril 65 1996 13 18
31. M.A. Rossing, and J.R. Daling Complexity of surveillance for cancer risk associated with in-vitro fertilisation Lancet 354 1999 1573 1574
32. K. Sanner, P. Conner, K. Bergfeldt, P. Dickman, K. Sundfeldt, and T. Bergh Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden Fertil Steril 91 2009 1152 1158
33. S. Fishel, and P. Jackson Follicular stimulation for high tech pregnancies: are we playing it safe? BMJ 299 1989 309 311
34. S.G. Derman, and E.Y. Adashi Adverse effects of fertility drugs Drug Saf 11 1994 408 421
35. A.F. Glasier Clomiphene citrate Baillieres Clin Obstet Gynaecol 43 1990 491 501
36. P. Merviel, R. Cabry, V. Boulard, E. Lourdel, M.F. Olieric, and C. Claeys Ovarian stimulation and follicular puncture risks [French.] Gynecol Obstet Fertil 37 2009 926 933
37. C.C. Orgeas, K. Sanner, P. Hall, P. Conner, J. Holte, and S.J. Nilsson Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study Am J Obstet Gynecol 200 2009 72 77
38. D. Katz, O. Paltiel, T. Peretz, A. Revel, N. Sharon, and B. Maly Beginning IVF treatments after age 30 increases the risk of breast cancer: results of a case-control study Breast J 14 2008 517 522
39. P. Kristiansson, O. Bjor, and H. Wramsby Tumour incidence in Swedish women who gave birth following IVF treatment Hum Reprod 22 2007 421 426
40. I. Pappo, L. Lerner-Geva, A. Halevy, L. Olmer, S. Friedler, and A. Raziel The possible association between IVF and breast cancer incidence Ann Surg Oncol 15 2008 1048 1055
41. L.M. Stewart, C.D. Holman, R. Hart, M.K. Bulsara, D.B. Preen, and J.C. Finn In vitro fertilization and breast cancer: is there cause for concern? Fertil Steril 98 2012 334 340
42. L.A. Brinton, D. Richesson, M.F. Leitzmann, G.L. Gierach, A. Schatzkin, and T. Mouw Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study cohort Cancer Epidemiol Biomarkers Prev 17 2008 3150 3160
43. H. Sovino, T. Sir-Petermann, and L. Devoto Clomiphene citrate and ovulation induction Reprod Biomed Online 4 2002 303 310
44. M. Varras, D. Polyzos, and C. Akrivis Effects of tamoxifen on the human female genital tract: review of the literature Eur J Gynaecol Oncol 24 2003 258 268
45. P. Doyle, N. Maconochie, V. Beral, A.J. Swerdlow, and S.L. Tan Cancer incidence following treatment for infertility at a clinic in the UK Hum Reprod 17 2002 2209 2213
46. A. Jensen, H. Sharif, J.H. Olsen, and S.K. Kjaer Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women Am J Epidemiol 168 2008 49 57
47. M.A. Rossing, J.R. Daling, N.S. Weiss, D.E. Moore, and S.G. Self In situ and invasive cervical carcinoma in a cohort of infertile women Fertil Steril 65 1996 19 22
48. R. Raz, O. Shavit, M. Stein, R. Cohen, E. Schejter, and G. Chodick Uptake of Pap smears among women in a large Israeli HMO between 2006 and 2008 Public Health 126 2012 594 599
49. S.H. Chung, S. Franceschi, and P.F. Lambert Estrogen and ERalpha: culprits in cervical cancer? Trends Endocrinol Metab 21 2010 504 511
50. L.A. Brinton, G. Gridley, I. Persson, J. Baron, and A. Bergqvist Cancer risk after a hospital discharge diagnosis of endometriosis Am J Obstet Gynecol 176 1997 572 579
51. L.A. Brinton, L.C. Sakoda, K. Frederiksen, M.E. Sherman, S.K. Kjaer, and B.I. Graubard Relationships of uterine and ovarian tumors to pre-existing chronic conditions Gynecol Oncol 107 2007 487 494
52. C.L. Pearce, C. Templeman, M.A. Rossing, A. Lee, A.M. Near, and P.M. Webb Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies Lancet Oncol 13 2012 385 394
53. H.A. Risch Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone J Natl Cancer Inst 90 1998 1774 1786